Analysis of viral and cellular gene expression during progression and suppression of the transformed phenotype in type 5 adenovirus-transformed rat embryo cells - PubMed (original) (raw)

. 1991 Oct;6(10):1813-24.

Affiliations

PMID: 1923506

Analysis of viral and cellular gene expression during progression and suppression of the transformed phenotype in type 5 adenovirus-transformed rat embryo cells

G J Duigou et al. Oncogene. 1991 Oct.

Abstract

Transformation of secondary Sprague-Dawley rat embryo (RE) cells with type 5 adenovirus (Ad5) results in morphologically transformed cells which can undergo a series of sequential changes resulting in enhanced expression of the transformed phenotype, a process termed progression. Selection for a progressed phenotype often occurs after growth in agar or tumor formation in nude mice, and this process is reversible following treatment of cells with 5-azacytidine. In the present study we have analyzed a series of clonal populations of Ad5-transformed RE cells representing different stages in a defined progression lineage. Progression was not associated with alterations in the steady-state levels of mRNA produced by the viral transforming genes, E1A and E1B, or the cellular gene, c-myc. In addition, the tumor-promoting agent 12-O-tetradecanoyl-phorbol-13-acetate (TPA), which induces expression of a progressed phenotype in Ad5-transformed RE cells, did not significantly alter the RNA transcription rates of the Ad5 E1A or E1B genes, the TPA-inducible gene TPA-S1 or the TPA-responsive genes Pro1 or protein kinase C. TPA did, however, increase by 1 h the steady-state level of c-fos mRNA, but this effect was similar in both progressed and unprogressed cells. Progression also did not involve a change in the RNA transcription rate of a number of cellular and viral genes, including actin, c-Ha-ras, c-myc, v-fos, erbB, TGF-alpha, TGF-beta, Pro-2, transin, TPA-R1, v-myb and c-mos, or other adenovirus genes in addition to E1A and E1B, including E2A and E4. Immunoblotting analysis using E1B polyclonal antiserum further indicated that progression was not associated with changes in the levels of an Mr 21,000 polypeptide encoded by E1B. Similarly, immunoprecipitation analysis with an Ad2 E1A monoclonal antibody indicated similar levels of the Mr 55,000 and 48,000 E1A polypeptides, as well as coprecipitated proteins of Mr 300,000, 107,000 and 105,000 [which is the retinoblastoma (Rb) protein], in E11 and E11-NMT cells. Immunoprecipitation of cell lysates with a monoclonal antibody specific for the Mr 105,000 Rb protein further demonstrated that progression also was not associated with a change in the level or state of phosphorylation of the Rb protein. However, transfection of a human Rb gene (also containing a neomycin resistance gene) into Ad5-transformed RE cells was more inhibitory, with respect to formation of G418-resistant colonies, in unprogressed than in progressed Ad5-transformed RE cells.(ABSTRACT TRUNCATED AT 400 WORDS)

PubMed Disclaimer

Cited by

Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.
Su Z, Goldstein NI, Fisher PB. Su Z, et al. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1764-9. doi: 10.1073/pnas.95.4.1764. Proc Natl Acad Sci U S A. 1998. PMID: 9465091 Free PMC article.
Subtraction hybridization identifies a transformation progression-associated gene PEG-3 with sequence homology to a growth arrest and DNA damage-inducible gene.
Su ZZ, Shi Y, Fisher PB. Su ZZ, et al. Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9125-30. doi: 10.1073/pnas.94.17.9125. Proc Natl Acad Sci U S A. 1997. PMID: 9256446 Free PMC article.
DMSO, sodium butyrate, and TPA induce hypophosphorylation of RB with HL-60 cell differentiation.
Yen A, Varvayanis S. Yen A, et al. In Vitro Cell Dev Biol Anim. 1995 Mar;31(3):164-7. doi: 10.1007/BF02639427. In Vitro Cell Dev Biol Anim. 1995. PMID: 7757295 No abstract available.

Analysis of viral and cellular gene expression during progression and suppression of the transformed phenotype in type 5 adenovirus-transformed rat embryo cells - PubMed (original) (raw)